conclusions.tex 9.4 KB

123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150
  1. % %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
  2. % Author: Phillip Rothenbeck
  3. % Title: Your Thesis
  4. % File: conclusions/conclusions.tex
  5. % Part: conclusions
  6. % Description:
  7. % summary of the content in this chapter
  8. % Version: 01.09.2024
  9. % %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
  10. \chapter{Conclusions}
  11. \label{chap:conclusions}
  12. The severe COVID-19 pandemic~\cite{WHO} infected millions of people, while hundreds of thousands
  13. succumbed to it in Germany alone~\cite{SRD}. Over three years the pandemic
  14. changed through the influence of various mitigation policies and numerous
  15. emerging variants. In order to get a hold of the complex situation the necessity
  16. for analysis arises. Therefore, the objective of this thesis is to measure the
  17. COVID-19 pandemic in Germany and its 16 federal states by identifying several
  18. epidemiological parameters that describe the spread of the disease. \\
  19. We use the SIR model~\cite{1927} to describe the dynamics of the COVID-19
  20. infection over time, offering an approximation of reality. In this model, the
  21. transmission rate $\beta$ and recovery rate $\alpha$
  22. describe the infectiousness and development of the disease that the respective
  23. population experience. These rates serve as global evaluation measures
  24. throughout the entire duration of the pandemic. Meanwhile, the time-dependent
  25. reproduction number indicates the number of individuals infected by a single infectious
  26. individual. The relations between parameters are defined in the system
  27. of differential equations which governs the SIR model.\\
  28. In order to obtain these epidemiological parameters and the reproduction number
  29. for Germany, it is necessary to solve the system of ordinary differential equations (ODEs)
  30. for real-world pandemic data recorded in each state and in Germany as a whole.
  31. One method that has gained significant attention in recent years for solving
  32. systems of differential equations is the data-driven approach known as
  33. \emph{Physics-Informed Neural Networks} (PINN)~\cite{Raissi2019}. PINNs
  34. integrate knowledge in form of physical models, while learning an approximation
  35. the solution by fitting data points. We adapt previous epidemiological PINN
  36. approaches~\cite{Shaier2021,Millevoi2023} to solve the set of ODEs of the SIR
  37. model. The data for training is collected by the Robert Koch Institute and made
  38. publicly available on GitHub~\cite{GHDead,GHInf}. After preprocessing, we
  39. solve the inverse problem posed by the SIR model utilizing PINNs in order to find the
  40. epidemiological parameters and the reproduction number for the given data. Using
  41. this we conduct experiments on synthetic data and on the data for the federal
  42. states and Germany itself. The results for the synthetic data yield a small
  43. error, which demonstrates the efficacy of our approach on small datasets.\\
  44. We divide our analysis of the real-world data into two groups. First, we have
  45. the time-constant epidemiological parameters $\alpha$ and $\beta$, which
  46. provide insight into the overall trajectory of the pandemic in a given region.
  47. Given the assumed constant recovery period (see~\Cref{sec:preprocessing:rq}),
  48. there is a dependency between the two parameters. Therefore, we focus our analysis on the
  49. transmission rate $\beta$. The states with the highest estimated transmission rate values
  50. are Thuringia, Saxony-Anhalt, and Mecklenburg-Western Pomerania, which means that
  51. these states had a higher average number of infections during the pandemic.
  52. Furthermore, it is evident that the six eastern states exhibit a higher transmission
  53. rate than the overall German rate (see~\Cref{fig:alpha_beta_mean_std}).
  54. Our results align with similarly observed differences in vaccination rates~\cite{FMH}
  55. and highlight perceived discrepancies between the eastern and western federal
  56. states~\cite{FMH,Desson2022}. We further substantiate this observation by
  57. calculating the correlation coefficient between the vaccination
  58. ratios $\nu$ of each state and our findings of $\beta$, which yields a strong
  59. negative correlation. In other words, a lower vaccination rate is an indicator
  60. for higher infection rates. The results from our second experiments,
  61. underscore these findings. Here, we approximate the time-independent reproduction number $\Rt$
  62. from the data. When $\Rt>1$, the disease spreads rapidly through the population.
  63. Our results indicate a tendency for states with a high $\beta$ to experience
  64. longer periods with $\Rt>1$. Furthermore, we can identify the time point on
  65. which the most impactful events happened during the pandemic in Germany such as
  66. the peak of the omicron variant~\cite{COVIDChronik} at around 700 days after
  67. the start of data collection on 2020-03-09.\\
  68. In conclusion, our approach has proven effective in yielding meaningful results
  69. for the epidemiological parameters of $\alpha$ and $\beta$, as well as the
  70. reproduction number $\Rt$ for Germany and its federal states. Despite the SIR
  71. model being an approximation of reality, there is a clear connection between the
  72. results and real-world data and events. We hope that this work will prove useful
  73. in the analysis of the events of the COVID-19 pandemic in Germany.
  74. % -------------------------------------------------------------------
  75. \section{Further Work}
  76. \label{sec:furtherWork}
  77. Our findings demonstrate that our methods enable the quantification of the
  78. course of the COVID-19 pandemic in Germany using the data provided by the
  79. Robert Koch Institute~\cite{GHDead,GHInf}. Here we present some limitations of
  80. our work and propose future directions to address these points. First, we find
  81. that our model does not accurately reconstruct the input data to the desired
  82. level of precision. To address this, we propose a comprehensive hyperparameter
  83. search to find the best configuration. Moreover, the SIR model does not
  84. account for individuals, who may be immune due to the vaccination status or
  85. those who are not infectious due to quarantine. In this section, we explore
  86. epidemiological models that incorporate such dynamics observed in real-world
  87. pandemics and recommend further investigation for Germany.
  88. % -------------------------------------------------------------------
  89. \subsection{Further Compartmental Models}
  90. As our results demonstrate, the SIR model is capable of approximating the
  91. dynamics of real-world pandemics. However, the model is not without
  92. limitations. The SIR model assumes that recovered
  93. individuals remain immune and does not account for the reduction of exposure to
  94. susceptible individuals through the introduction of non-pharmaceutical
  95. mitigation policies, such as social distancing policies. These shortcomings can
  96. be addressed by incorporating additional compartments and transmission rates
  97. into the model. For example, the SEIRD model~\cite{Korolev2021} incorporates an
  98. \emph{Exposed} group and subdivides the \emph{Removed} group into \emph{Dead}
  99. and \emph{Recovered} compartments. Furthermore, the model is extended with four
  100. additional parameters: the contact rate, the manifestation index, the incubation
  101. rate, and the infection fatality rate. Doerre and Doblhammer~\cite{Doerre2022}
  102. introduce an approach utilizing a SIERD model that they specialize to be age-
  103. and gender-specific. For Germany, they show the impact of non-pharmaceutical
  104. mitigation policies, solving the model using a numerical approximation method.\\
  105. Additionally, Cooke and van den Driessche~\cite{Cooke1996}
  106. propose the SEIRS model with two delays. This model is capable of
  107. approximating diseases, that have an immune period, after which the recovered
  108. individual becomes susceptible again. These are just a few examples of
  109. the numerous modifications of the basic SIR model that can display the dynamics
  110. of the real world in a higher degree of detail and may be used to approximate
  111. and consequently quantify a pandemic.
  112. % -------------------------------------------------------------------
  113. \subsection{Agent based models}
  114. Compartmental models, such as the SIR model, look at the population as a
  115. divided group. Each group represents a specific characterization that
  116. all inhabitants of that group share. An \emph{Agent-Based Model} (ABM) sets its
  117. focus on the individual. Each individual, or agent, has specific attributes
  118. that determine its behavior and interactions with other agents during the
  119. simulation. As Gilbert~\cite{Gilbert2010} states, ABMs simulate the behavior of
  120. large groups. Each individual follows simple rules which leads to the emergence
  121. of complex and stochastic behaviour on the mascroscopic level of the
  122. system~\cite{Bodine2020}. With regard to COVID-19, Kerr \etal~\cite{Kerr2021}
  123. put forth a simulation tool, \emph{Covasim}, which they base on an ABM. The ABM
  124. employs local data, including demographic data, disease incidence data from the
  125. region, and contact data for household, schools and workplaces, to define its
  126. simulation for a specific region. Maziarz and Zach~\cite{Maziarz2020} address
  127. the criticism levied against ABMs for simplifying the dynamics and lacking the
  128. empirical support for the assumptions they make. The authors utilize an ABM and
  129. the data specific to Australia to demonstrate the efficacy of ABMs in portraying
  130. the dynamics of the COVID-19 pandemic. They state that ABMs can serve as a tool
  131. for assessing the impact of non-pharmaceutical mitigation policies. This
  132. illustrates that ABMs play a distinct role in analyzing the COVID-19 pandemic.
  133. As the quantity of data has evolved, it is imperative to investigate the
  134. potential of utilizing ABMs as a tool to assess the pandemic's course for
  135. Germany in greater detail.
  136. % -------------------------------------------------------------------